Thioester stapled peptide, preparation method and application thereof
A technology for stapling peptides and thioesters, applied in the field of peptides, to avoid product isomerization
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0042] Example 1 Synthesis of Thioester Stapled Peptide
[0043] raw material
[0044] Buffer A: 6M Guanidine Hydrochloride, 100mM Na 2 HPO4 ,pH=8.5;
[0045] Buffer B: 6M Guanidine Hydrochloride, 100mM NaH 2 PO 4 ,pH=2.5;
[0046] Table 3 Linear peptides
[0047]
[0048] The linear peptides shown in Table 3 can be prepared by solid-phase polypeptide synthesis (SPPS).
[0049] The preparation of thioester-stapled peptide by linear peptide PS1-1-1 is described below as an example, and the operation of preparing thioester-stapled peptide by other linear peptides is the same.
[0050] synthetic route:
[0051]
[0052] Synthetic steps:
[0053] (a) Cys is removed to Dha
[0054] Dissolve linear peptide PS1-1-1 (50 mg) in buffer B (3 mL), then slowly drop into buffer A (47 mL) dissolved with 2,5-dibromoadipamide (75 mg), at room temperature After stirring overnight, HPLC detected that the reaction was complete, purified by preparative liquid phase and lyophilized ...
Embodiment 2
[0060] Embodiment 2 Fluorescence polarization binding experiment
[0061] First, TAMRA-NHS (tetramethylrhodamine-N-hydroxysulfosuccinimide) was covalently linked to the N-terminal amino group of PMI (TSFAEYWNLLSP), and a fluorescent label with TAMRA as the fluorescent group was obtained. The peptide PMI-TAMRA was subsequently determined to have binding constants of 0.62 nM and 0.72 nM for PMI-TAMRA to MDM2 and MDMX, respectively. In order to verify the specificity of this method, the competitive binding constant K of the complex system of PMI-TAMRA and MDM2 or MDMX was determined without fluorescent labeling i . In addition, as a control, the competitive binding constant K of Nutlin-3 to MDM2 or MDMX was determined at the same time i , are 5.1 nM and 1.54 μM, respectively, which are in agreement with the reported K i The values are basically the same. K i The smaller it is, the higher the binding ability is, and the modified polypeptide PMI of the present invention has ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com